![Ashish Bhatia MD, FAAD](https://res.cloudinary.com/els-assets/image/upload/f_auto,w_120,c_thumb,ar_1:1,g_face/r_max,bo_2px_solid_rgb:d3d3d37F/practice-update/remote-media/contentimage/35303.jpg)
Ashish C. Bhatia MD, FAAD
Associate Professor of Clinical Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois; Co-Founder, Director of Clinical Research, and Co-Director, Dermatologic, Laser and Cosmetic Surgery, Oak Dermatology, Itasca, Joliet, and Naperville, IllinoisDr. Ashish Bhatia is a board-certified and fellowship-trained dermatologist and dermatologic surgeon. He is an Associate Professor of Clinical Dermatology at Northwestern University Feinberg School of Medicine in Chicago and the Director of Dermatologic, Laser, and Cosmetic Surgery at Oak Dermatology (locations in Itasca, Joliet, and Naperville, Illinois).
Dr. Bhatia is a recognized expert in dermatologic surgery and cosmetic surgery. His clinical expertise includes Mohs and reconstructive surgery, skin cancer therapy and prevention, laser surgery, skin resurfacing procedures, and cosmetic procedures including lasers, fillers, and neuromodulators. He also has a special interest in restorative procedures for adults and children with burns, surgical scars, and traumatic scars.
After receiving his medical degree from Northeastern Ohio University College of Medicine, Dr. Bhatia completed his residency in dermatology at the Medical College of Virginia Hospitals, where he served as Chief Resident. Subsequently, he completed an intensive fellowship in Mohs surgery, cutaneous oncology, and reconstruction, cosmetic, and laser surgery at SkinCare Physicians in Boston, Massachusetts.
Disclosures
- Grants/research: AbbVie; Alastin Skincare; Avita Medical; Cutera; Medline; NovaScan; Pulse Biosciences; R2 Technologies; Revance
- Consulting/advisory boards: Alastin Skincare; Allergan/AbbVie; Arcutis; Avita Medical; Bausch Health; Carpe; Cutera; Cytrellis; Emblation Ltd; Endo Aesthetics; Entrepix Medical; Evolus; Medline; MiMEDx; Obagi; Ortho Dermatologics; RBC Consultants; Revance; Solta; Sofwave; Strata Skin Sciences; Theravant Corp
- Speaker bureau: Allergan; Cutera; DermEd Foundation; Evolus; Medline; MiMEDx; Ortho Dermatologics; Paradigm Medical; Revance; Theravant Corp
- Ownership interest/shareholder: Biomarck; Carpe; Cutera; Derma MD; Genzum; SimSkin; Sonoma; Theravant Corp; Zalea
- Stock/options: AbbVie; Bausch Health; Biomarck; Carpe; Cutera; Cytrellis; Strata Skin Health
- Executive role/board member: Theravant Corp; DermEd Foundation
Recent Contributions to PracticeUpdate:
- Patient Perception of Demographic and Socioeconomic Barriers to Outpatient Dermatologic Care
- Ruxolitinib and Its Association With NMSC in Polycythemia Vera and Myelofibrosis Patients
- Contact Allergy to Acrylates in Apple AirPods Pro® Headphones
- Cutaneous Manifestations in Patients With and Without Housing
- Biological Therapy Interruption and Re-Treatment in Chronic Plaque Psoriasis
- Differences in Acne Therapy Prescribing Patterns Between Dermatologists and Pediatricians
- Community Education Tool for Detection of Nail Melanoma by Nail Salon Technicians
- Anecdote Increases Patient Willingness to Take a Biologic Medication
- Cutaneous Reactions After SARS-CoV-2 Vaccination
- Opioid Prescriptions Obtained After Mohs Surgery